当前位置:首页 - 行情中心 - 三力制药(603439) - 财务分析 - 现金流量表

三力制药

(603439)

  

流通市值:54.44亿  总市值:54.44亿
流通股本:4.04亿   总股本:4.04亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金781,279,533.28378,199,568.481,858,198,458.161,326,555,727
  收到的税费返还1,564,627.641,092,635.141,926,582.231,694,742.23
  收到其他与经营活动有关的现金15,515,770.191,550,238.4359,772,017.7239,128,906.63
  经营活动现金流入小计798,359,931.11380,842,442.051,919,897,058.111,367,379,375.86
  购买商品、接受劳务支付的现金131,185,143.2170,179,722.84490,853,740.74399,230,830.01
  支付给职工以及为职工支付的现金120,904,087.4967,301,644.05319,776,028.09250,116,414.12
  支付的各项税费109,300,629.3365,069,684.13193,103,919.71139,405,239.75
  支付其他与经营活动有关的现金325,995,220.43164,697,605.83751,586,345.2528,563,256.81
  经营活动现金流出小计687,385,080.46367,248,656.851,755,320,033.741,317,315,740.69
  经营活动产生的现金流量净额110,974,850.6513,593,785.2164,577,024.3750,063,635.17
二、投资活动产生的现金流量:
  取得投资收益收到的现金1,409,183.14400,517.87657,842.82494,460.46
  处置固定资产、无形资产和其他长期资产收回的现金净额420,050-639,687.5458,987.5
  收到的其他与投资活动有关的现金538,270,00088,000,000103,015,00061,300,000
  投资活动现金流入小计540,099,233.1488,400,517.87104,312,530.3262,253,447.96
  购建固定资产、无形资产和其他长期资产支付的现金19,630,767.115,206,19825,838,199.5723,814,915.96
  投资支付的现金--206,830,000206,830,000
  支付其他与投资活动有关的现金521,500,000244,000,000100,079,654.0498,099,654.04
  投资活动现金流出小计541,130,767.11249,206,198332,747,853.61328,744,570
  投资活动产生的现金流量净额-1,031,533.97-160,805,680.13-228,435,323.29-266,491,122.04
三、筹资活动产生的现金流量:
  取得借款收到的现金307,685,871.4867,144,950.08570,543,303.5449,638,000
  筹资活动现金流入小计307,685,871.4867,144,950.08570,543,303.5449,638,000
  偿还债务支付的现金429,108,584.6104,204,676.5418,906,778.97276,481,778.97
  分配股利、利润或偿付利息支付的现金33,888,422.544,524,802.65161,443,697.28155,606,886.5
  其中:子公司支付给少数股东的股利、利润346,869--645,894
  支付其他与筹资活动有关的现金35,012,400286,40011,760,182.3610,276,172.77
  筹资活动现金流出小计498,009,407.14109,015,879.15592,110,658.61442,364,838.24
  筹资活动产生的现金流量净额-190,323,535.66-41,870,929.07-21,567,355.117,273,161.76
五、现金及现金等价物净增加额-80,380,218.98-189,082,824-85,425,654.03-209,154,325.11
  加:期初现金及现金等价物余额389,417,360.31389,417,360.31474,843,014.34474,845,014.34
  期末现金及现金等价物余额309,037,141.33200,334,536.31389,417,360.31265,690,689.23
补充资料:
  净利润37,790,787.92-48,153,602.74-
  资产减值准备2,732,353.41-129,825,096.73-
  固定资产和投资性房地产折旧23,891,436.16-53,951,010.1-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧23,891,436.16-53,951,010.1-
  无形资产摊销9,378,597.18-18,867,980.04-
  长期待摊费用摊销262,677.64-317,341.47-
  处置固定资产、无形资产和其他长期资产的损失-309,851.44-115,565.58-
  固定资产报废损失185.5-31,973.43-
  公允价值变动损失-6,475.6--155,822.2-
  财务费用9,391,256.81-25,304,530.19-
  投资损失-651,292.63-2,772,299.71-
  递延所得税206,186.26--4,173,133.44-
  其中:递延所得税资产减少2,008,101.41--664,747.14-
    递延所得税负债增加-1,801,915.15--3,508,386.3-
  存货的减少-4,957,258.53-92,678,699.28-
  经营性应收项目的减少187,311,468.56-196,233,956.34-
  经营性应付项目的增加-157,766,230.15--408,689,731.19-
  其他6,558,374.86-13,725,903.98-
  不涉及现金收支的投资和筹资活动金额其他项目--3,848,216.64-
  现金的期末余额309,037,141.33-389,417,360.31-
  减:现金的期初余额389,417,360.31-474,843,014.34-
  现金及现金等价物的净增加额-80,380,218.98--85,425,654.03-
公告日期2026-08-282026-04-272026-04-272025-10-28
审计意见(境内)标准无保留意见
TOP↑